These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 15307034)

  • 1. Perirenal fat diameter measured by echography could be an early predictor of lipodystrophy in HIV type 1-infected patients receiving highly active antiretroviral therapy.
    Asensi V; Martín-Roces E; Carton JA; Collazos J; Maradona JA; Alonso A; Medina M; Aburto JM; Martínez E; Rojo C; Bustillo E; Fernández C; Arribas JM
    Clin Infect Dis; 2004 Jul; 39(2):240-7. PubMed ID: 15307034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between physical and echographic fat thickness assessments and a lipodystrophy grading scale in lipodystrophic HIV patients: practical implications.
    Asensi V; Martín-Roces E; Collazos J; Cartón JA; Maradona JA; Alonso A; Medina M; Aburto JM; Fernández C; Martínez E
    AIDS Res Hum Retroviruses; 2006 Sep; 22(9):830-6. PubMed ID: 16989606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasonographic assessment of lipodystrophy in HIV-1-infected patients.
    Grima PF; Chiavaroli R; Grima P
    Radiol Med; 2009 Feb; 114(1):141-51. PubMed ID: 18956151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipodystrophy and echographic hepatic steatosis in HIV-positive patients under highly active antiretroviral therapy (HAART) in Yaounde (Cameroon)].
    Ongolo-Zogo P; Nkodo Mbia N; Mvogo Minkala TL; Biwole Sida M; Kouanfack C; Nko Amvene S
    Bull Soc Pathol Exot; 2012 Dec; 105(5):353-60. PubMed ID: 22886433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy.
    Sutinen J; Häkkinen AM; Westerbacka J; Seppälä-Lindroos A; Vehkavaara S; Halavaara J; Järvinen A; Ristola M; Yki-Järvinen H
    AIDS; 2002 Nov; 16(16):2183-93. PubMed ID: 12409740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose tissue inflammation and liver fat in patients with highly active antiretroviral therapy-associated lipodystrophy.
    Sevastianova K; Sutinen J; Kannisto K; Hamsten A; Ristola M; Yki-Järvinen H
    Am J Physiol Endocrinol Metab; 2008 Jul; 295(1):E85-91. PubMed ID: 18430964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV- 1/HAART-associated lipodystrophy.
    Giralt M; Domingo P; Guallar JP; Rodriguez de la Concepción ML; Alegre M; Domingo JC; Villarroya F
    Antivir Ther; 2006; 11(6):729-40. PubMed ID: 17310817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus-associated lipodystrophy: an objective definition based on dual-energy x-ray absorptiometry-derived regional fat ratios in a South Asian population.
    Asha HS; Seshadri MS; Paul TV; Abraham OC; Rupali P; Thomas N
    Endocr Pract; 2012; 18(2):158-69. PubMed ID: 21856599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of glucose uptake by skeletal muscle tissue and subcutaneous fat in HIV-infected patients with and without lipodystrophy using FDG-PET.
    Sathekge M; Maes A; Kgomo M; Stolz A; Ankrah A; Van de Wiele C
    Nucl Med Commun; 2010 Apr; 31(4):311-4. PubMed ID: 20145581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipodystrophy and metabolic disorders in HIV-1-infected adults on 4- to 9-year antiretroviral therapy in Senegal: a case-control study.
    Mercier S; Gueye NF; Cournil A; Fontbonne A; Copin N; Ndiaye I; Dupuy AM; Cames C; Sow PS; Ndoye I; Delaporte E; Simondon KB
    J Acquir Immune Defic Syndr; 2009 Jun; 51(2):224-30. PubMed ID: 19339897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population.
    Hansen AB; Lindegaard B; Obel N; Andersen O; Nielsen H; Gerstoft J
    HIV Med; 2006 Jan; 7(1):38-45. PubMed ID: 16313291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fat Mass Ratio in Brazilian HIV-infected Patients Under Antiretroviral Therapy and Its Relationship With Anthropometric Measurents.
    Bicudo Bruno Nogueira A; Abreu JM; Mesquita Villela M; Boracini Sanchez AE; Silva Chaves B; Setubal S; Coca Velarde LG; Cruz Filho RAD; Balarini Lima GA; Soares DV
    J Clin Densitom; 2020; 23(4):623-629. PubMed ID: 30545683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study.
    Young J; Rickenbach M; Weber R; Furrer H; Bernasconi E; Hirschel B; Tarr PE; Vernazza P; Battegay M; Bucher HC
    Antivir Ther; 2005; 10(1):73-81. PubMed ID: 15751765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased resting energy expenditure, fat oxidation, and food intake in patients with highly active antiretroviral therapy-associated lipodystrophy.
    Sutinen J; Yki-Järvinen H
    Am J Physiol Endocrinol Metab; 2007 Mar; 292(3):E687-92. PubMed ID: 17062843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epicardial adipose tissue is related to carotid intima-media thickness and visceral adiposity in HIV-infected patients with highly active antiretroviral therapy-associated metabolic syndrome.
    Iacobellis G; Sharma AM; Pellicelli AM; Grisorio B; Barbarini G; Barbaro G
    Curr HIV Res; 2007 Mar; 5(2):275-9. PubMed ID: 17346142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Criteria for AIDS-prices 2003. Why does HAART therapy in HIV patients cause fat catabolism?].
    Urologe A; 2003 Sep; 42(9):1254. PubMed ID: 14619845
    [No Abstract]   [Full Text] [Related]  

  • 17. Circulating concentration of adiponectin and its expression in subcutaneous adipose tissue in patients with highly active antiretroviral therapy-associated lipodystrophy.
    Sutinen J; Korsheninnikova E; Funahashi T; Matsuzawa Y; Nyman T; Yki-Järvinen H
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1907-10. PubMed ID: 12679491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study.
    Martinez E; Mocroft A; García-Viejo MA; Pérez-Cuevas JB; Blanco JL; Mallolas J; Bianchi L; Conget I; Blanch J; Phillips A; Gatell JM
    Lancet; 2001 Feb; 357(9256):592-8. PubMed ID: 11558485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone in the treatment of HAART-associated lipodystrophy--a randomized double-blind placebo-controlled study.
    Sutinen J; Häkkinen AM; Westerbacka J; Seppälä-Lindroos A; Vehkavaara S; Halavaara J; Järvinen A; Ristola M; Yki-Järvinen H
    Antivir Ther; 2003 Jun; 8(3):199-207. PubMed ID: 12924536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.